Demirtas, C. Et Al. 2020. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.32, no.4 , 517-523.

Demirtas, C., Gunduz, F., Tuney, D., Baltacioglu, F., Kani, H. T., Bugdayci, O., ... Alahdab, Y.(2020). Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.32, no.4, 517-523.

Demirtas, CO Et Al. "Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients," EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.32, no.4, 517-523, 2020

Demirtas, CO Et Al. "Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.32, no.4, pp.517-523, 2020

Demirtas, C. Et Al. (2020) . "Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.32, no.4, pp.517-523.

@article{article, author={CO Demirtas Et Al. }, title={Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients}, journal={EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY}, year=2020, pages={517-523} }